Billings Clinic
Especially For:

Clinical Trials

Title   NSABP B-47: A Randomized Trial Comparing Chemotherapy Alone to Cheotherapy + Trasztuzumab
Description   A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (6 Cycles of Docetaxel Plus Cyclophosphamide or 4 Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapty Plus Trastuzumab in Women with Node Positive or High-Risk Node-Negative HER2/neu-Low Invasive Breast Cancer.
IRB Number   NSABP B-47
Category   Breast Cancer
Inclusion/Notes   HER2/neu low or negative.

Multiple, specific Inclusion/Exclusion Criteria need to be met to be able to participate in this clinical trial.
Status   Open to Enrollment
Start Date   02/11/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan Koch, R.N.
Contact Email   jkoch@billingsclinic.org
Phone   (406) 435-7481
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.